Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

U01 Pilot Trial of DUR-928 in Patients With Moderate and Severe Alcoholic Hepatitis

NCT03917407 is registered in ClinicalTrials.gov with Craig James McClain as lead sponsor.

NCT NCT03917407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03917407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
U01 Pilot Trial of DUR-928 in Patients With Moderate and Severe Alcoholic Hepatitis
Lead sponsor
Craig James McClain
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2021
Completion date
September 30, 2023
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis